Merck Inbio Agreement

The irresponsibility is unbelievable, wrote a visibly angry Ortiz Volio in an editorial, as was the initial arrogance, and two decades later, bankrupt, they hand over everything the state has to pay. [14] (INBio did not go bankrupt technically, but could not pay its bills. INBio-Management expropriated the process by mutual agreement.) [15] Bioprospecting has not been tested. The Merck-INBio deal was scrapped in 2011 and costa Rica`s revenue from research samples has never reached the $300 million a year it earns from coffee exports. Until 2013, INBio launched an appeal for public donations to pay employees` salaries. Eli Lilly, Bristol-Myers Squibb and other large multinationals have also abandoned their international bioprospeciesation projects. In the early 1990s, pharmaceutical giant Merck entered into a bioprospecting agreement with Costa Rica`s National Biodiversity Institute, known by the Spanish acronym INBio. Merck would have exclusive access to test the therapeutic potential of INBio`s vast collections of local organizations, in exchange for a million-dollar down payment, in-kind contributions to research, and a royalty promise in case commercial products are identified. Other Costa Rican biologists were equally critical and found that INBio benefited from many confidential bioprospecies agreements, without public accountancy, which they compared with the efforts of indigenous peoples, local communities and other NGOs to develop Costa Rica`s Biodiversity Law, which contains access rules and benefit compensation rules. INBio makes what has never been part of it, they write, referring to biodiversity collections, saying that over the past two decades they could have been better used to support protected areas rather than INBio itself.

[16] INBios` BEST-KNOWN DEAL was an agreement with pharmaceutical company Merck in 1991, even before CBD was signed at the Earth Summit in Rio de Janeiro, Brazil, in 1992. At the Earth Summit and subsequently, the Merck-INBio agreement was hailed as a harbinger of a new era for medicines extracted from the rainforest, which will bring great financial benefits to developing countries. The Merck deal was called a success until the 2000s, although Merck ignored the deal in 2008 and gave away its natural link library in 2011, as if it wanted to celebrate the [20th] anniversary of its Costa Rican madness. [9] [6] Rojas P (2015). INBio seguir al frente del INBioparque por un ao ms, tras acuerdo con el gobierno. crhoy.com noticias (website), 31 March. URL: www.crhoy.com/del-dia-inbio-seguira-al-frente-del-inbioparque-por-un-ano-mas-tras-acuerdo-con-el-gobierno/ [12] Wade, Lizzie (2014). The famous Biodiversity Institute is facing a financial crisis. Science, December 19. Since I first wrote about bioprospection, I have continued to study the broader and evolving field of ecosystem services.

I was the author of the Millennium Ecosystem Assessment, Review Editor of the Un-sponsored project „The Economics of Ecosystems and Biodiversity” and Advisor to the World Bank`s Program for Accounting and Evaluation of Ecological Services. I continued to study issues such as pollination, storm protection, and dealing with pollution of natural systems. and I worked for several years as Director of Ecosystem Economic Studies at the U.S. Environmental Protection Agency`s National Center for Environmental Economics. . . .